GW & Wade’s Cantel Medical Corporation CMD Stock Holding History

GW & Wade’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,619	Closed	-$247K	–	243
2017 Q3	$247K	Buy	+2,619	New	+$207K	0.03%	206

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

GW & Wade's CMD Position: Q4 2017 in Review

GW & Wade sold out of Cantel Medical Corporation (CMD) in Q4 2017, closing a stake of 2,619 shares — an estimated $247K sold.

GW & Wade first reported a position in CMD in Q3 2017 and held it in 1 quarter. The position peaked at $247K in Q3 2017. 245 funds tracked by Wall St. Rank hold CMD as of Q4 2017.

GW & Wade reported no remaining Cantel Medical Corporation position as of Q4 2017 after selling out during the quarter.
GW & Wade sold 2,619 Cantel Medical Corporation shares in Q4 2017, an estimated $247K.
GW & Wade first reported a position in Cantel Medical Corporation in Q3 2017 and held it in 1 quarter.
GW & Wade's Cantel Medical Corporation position peaked at $247K in Q3 2017.
245 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2017.

Based on GW & Wade's 13F filing for Q4 2017, filed 13 Feb 2018.